As of 2025-01-17, the Relative Valuation of Affimed NV (AFMD) is (59.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.08 USD, the upside of Affimed NV based on Relative Valuation is -5579.7%.
The range of the Relative Valuation is (40.00) - (74.36) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.5x - 15.8x | 12.2x |
| Forward P/E multiples | 8.5x - 17.5x | 13.0x |
| Fair Price | (40.00) - (74.36) | (59.18) |
| Upside | -3804.0% - -6985.0% | -5579.7% |
| Date | P/E |
| 2025-01-03 | -0.29 |
| 2025-01-02 | -0.29 |
| 2024-12-31 | -0.25 |
| 2024-12-30 | -0.26 |
| 2024-12-27 | -0.27 |
| 2024-12-26 | -0.27 |
| 2024-12-24 | -0.26 |
| 2024-12-23 | -0.25 |
| 2024-12-20 | -0.25 |
| 2024-12-19 | -0.25 |
| 2024-12-18 | -0.27 |
| 2024-12-17 | -0.32 |
| 2024-12-16 | -0.45 |
| 2024-12-13 | -0.46 |
| 2024-12-12 | -0.46 |
| 2024-12-11 | -0.48 |
| 2024-12-10 | -0.49 |
| 2024-12-09 | -0.51 |
| 2024-12-06 | -0.50 |
| 2024-12-05 | -0.49 |
| 2024-12-04 | -0.53 |
| 2024-12-03 | -0.53 |
| 2024-12-02 | -0.59 |
| 2024-11-29 | -0.60 |
| 2024-11-27 | -0.60 |
| 2024-11-26 | -0.61 |
| 2024-11-25 | -0.64 |
| 2024-11-22 | -0.56 |
| 2024-11-21 | -0.56 |
| 2024-11-20 | -0.58 |
| 2024-11-19 | -0.64 |
| 2024-11-18 | -0.67 |
| 2024-11-15 | -0.74 |
| 2024-11-14 | -0.78 |
| 2024-11-13 | -0.80 |
| 2024-11-12 | -0.80 |
| 2024-11-11 | -0.81 |
| 2024-11-08 | -0.82 |
| 2024-11-07 | -0.81 |
| 2024-11-06 | -0.76 |
| 2024-11-05 | -0.78 |
| 2024-11-04 | -0.69 |
| 2024-11-01 | -0.69 |
| 2024-10-31 | -0.69 |
| 2024-10-30 | -0.71 |
| 2024-10-29 | -0.71 |
| 2024-10-28 | -0.72 |
| 2024-10-25 | -0.71 |
| 2024-10-24 | -0.71 |
| 2024-10-23 | -0.72 |